Somaiya Mayur Ian Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
3
Insider Sells Sum
$1.62M

Insider Activity of Somaiya Mayur Ian

According to the SEC Form 4 filings, Somaiya Mayur Ian, being in a position of

  1. Chief Financial Officer at NewAmsterdam Pharma Company N.V.,
    оver the last 12 months, has bought 0 shares, and sold 105118 shares for $3.43M,
    over all time since 2025-01-27, has bought 0 shares, and sold 178496 shares for $5.05M.

Biography of Somaiya Mayur Ian

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $3,430,7913100

Comparison of Insiders on Amount of Buys and Sells

2026-01-21SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Financial Officer
39,784
0.0347%
$33.59$1.34M-10.34%
2026-01-20SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Financial Officer
60,216
0.0524%
$31.96$1.92M-6.05%
2026-01-05SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Financial Officer
5,118
0.0045%
$33.25$170,174-8.09%
2025-01-28SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Financial Officer
14,900
0.0137%
$21.16$315,262+10.12%
2025-01-28SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Financial Officer
11,495
0.0105%
$20.93$240,590+10.12%
2025-01-27SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Financial Officer
46,983
0.0438%
$22.66$1.06M+4.42%
Total: 6
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.